Technology-Enhanced Quitline Services to Prevent Smoking Relapse (TEQ)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Alere Wellbeing
Kaiser Foundation Hospitals, Center for Health Research
University of Washington
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT00888992
First received: April 27, 2009
Last updated: June 6, 2013
Last verified: June 2013

April 27, 2009
June 6, 2013
April 2010
January 2015   (final data collection date for primary outcome measure)
Participant smoking status. [ Time Frame: 6 and 12 month follow-up ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00888992 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Technology-Enhanced Quitline Services to Prevent Smoking Relapse
Technology-Enhanced Quitline Services to Prevent Smoking Relapse

The purpose of this study is to see if automated telephone monitoring will enhance existing quitline services, such as Alere Wellbeing's Quit For Life program, and help people quit smoking. If successful, this intervention could be incorporated into existing quitline protocols and delivered to millions of people who are trying to quit smoking.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Smoking Cessation
  • Behavioral: Quitline Service + 10 automated monitoring calls
    This group will receive the usual care provided in Alere Wellbeing's Quit For Life® program. The program includes 5 telephone counseling calls. In addition, participants receive 10 automated telephone monitoring calls to help them stay off cigarettes. The automated call schedule will be two calls per a week for 2 weeks, then once a week for 6 weeks. Participants whose answers indicate that they may be having trouble quitting smoking will be automatically connected to a Quit Coach for individualized relapse prevention counseling.
  • Behavioral: Quitline service + 20 automated monitoring calls
    This group will receive the usual care provided in Alere Wellbeing's Quit For Life® program. The program includes 5 telephone counseling calls. In addition, participants receive 20 automated telephone monitoring calls to help them stay off cigarettes. The automated call schedule will be one automated call a day for 2 weeks, then once a week for 6 weeks. Participants whose answers indicate that they may be having trouble quitting smoking will be automatically connected to a Quit Coach for individualized relapse prevention counseling.
  • No Intervention: Group A
    Receive the usual care provided in Alere Wellbeing's Quit For Life® program. The program includes 5 telephone counseling calls.
  • Experimental: Group B
    Intervention: Behavioral: Quitline Service + 10 automated monitoring calls
  • Experimental: Group C
    Intervention: Behavioral: Quitline service + 20 automated monitoring calls
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1785
January 2015
January 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years or older
  • Enrolled in Free & Clear, Inc. services
  • Self-reported abstinence for at least 24 hours at the quit date call
  • Able to read and speak English
  • Personal access to a touch-tone telephone or cellular telephone

Exclusion Criteria:

  • Have not stopped smoking for 24 hours
  • Currently incarcerated
  • Currently participating in any other smoking cessation research
  • Live in same household as another study participant
  • Participated in the Alere Wellbeing Quit for Life Program within the last 6 months
  • Were previously enrolled in this study even if they repeat the smoking cessation program during the accrual period
  • Hearing impaired enrollees receiving Free & Clear services via telecommunications devices for the deaf (TDD) will be excluded from the study as the IVR technology currently does not have this capability
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00888992
0812-77B, 1R01CA138936-01
No
Indiana University
Indiana University
  • Alere Wellbeing
  • Kaiser Foundation Hospitals, Center for Health Research
  • University of Washington
Principal Investigator: Anna M McDaniel, PhD RN FAAN Indiana University
Principal Investigator: Susan Zbikowski, PhD Alere Wellbeing
Principal Investigator: Katie Witkiewitz, PhD University of New Mexico
Principal Investigator: Jeffery Fellows, PhD Kaiser Permanente
Indiana University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP